Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

United Therapeutics Corporation UTHR

Full chart Compare
Set alert

Price alert · UTHR

All alert types
608.49 USD +7.17 (+1.19%)

At closeNov 4, 2026, 6:22 PM EST

608.49 0.00 0.00%

After hours · Nov 4, 6:22 PM ET

578.28 Day range 614.23
432.53 52-week range 614.23
YTD
+24.88%
1 year
+39.14%

Financial health

Altman Z-Score

23.73 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 3
  • P/B 2

Valuation

P/E 16.2×
FY 2016: 8.8×FY 2017: 15.6×FY 2018: 8.0×FY 2019: -36.9×FY 2020: 13.0×FY 2021: 20.4×FY 2022: 17.4×FY 2023: 10.5×FY 2024: 13.3×FY 2025: 16.2×
FY 2016 5y median 16.2× FY 2025
P/S 6.8×
FY 2016: 3.9×FY 2017: 3.8×FY 2018: 2.9×FY 2019: 2.7×FY 2020: 4.5×FY 2021: 5.8×FY 2022: 6.5×FY 2023: 4.4×FY 2024: 5.5×FY 2025: 6.8×
FY 2016 5y median 5.8× FY 2025
P/B 3.0×
FY 2016: 3.4×FY 2017: 3.1×FY 2018: 1.7×FY 2019: 1.4×FY 2020: 2.0×FY 2021: 2.5×FY 2022: 2.6×FY 2023: 1.7×FY 2024: 2.5×FY 2025: 3.0×
FY 2016 5y median 2.5× FY 2025
P/FCF 20.7×
FY 2016: 10.5×FY 2017: 16.8×FY 2018: 8.0×FY 2019: -13.3×FY 2020: 9.6×FY 2021: 20.3×FY 2022: 19.1×FY 2023: 13.8×FY 2024: 14.8×FY 2025: 20.7×
FY 2016 5y median 19.1× FY 2025
EV/EBITDA 11.0×
FY 2016: 4.8×FY 2017: 5.7×FY 2018: 5.2×FY 2019: -53.0×FY 2020: 10.5×FY 2021: 13.0×FY 2022: 12.0×FY 2023: 7.1×FY 2024: 8.8×FY 2025: 11.0×
FY 2016 5y median 11.0× FY 2025
EV/Sales 6.3×
FY 2016: 3.3×FY 2017: 3.5×FY 2018: 2.7×FY 2019: 2.7×FY 2020: 4.6×FY 2021: 5.7×FY 2022: 6.5×FY 2023: 4.2×FY 2024: 5.1×FY 2025: 6.3×
FY 2016 5y median 5.7× FY 2025
FCF Yield 4.8%
FY 2016: 9.6%FY 2017: 6.0%FY 2018: 12.5%FY 2019: -7.5%FY 2020: 10.4%FY 2021: 4.9%FY 2022: 5.2%FY 2023: 7.3%FY 2024: 6.8%FY 2025: 4.8%
FY 2016 5y median 5.2% FY 2025

Profitability

Gross Margin 87.9%
FY 2016: 95.5%FY 2017: 93.9%FY 2018: 87.8%FY 2019: 91.9%FY 2020: 92.7%FY 2021: 92.7%FY 2022: 92.4%FY 2023: 88.9%FY 2024: 89.2%FY 2025: 87.9%
FY 2016 5y median 89.2% FY 2025
Operating Margin 47.7%
FY 2016: 66.4%FY 2017: 47.2%FY 2018: 49.5%FY 2019: -12.9%FY 2020: 40.0%FY 2021: 33.0%FY 2022: 50.6%FY 2023: 50.9%FY 2024: 47.9%FY 2025: 47.7%
FY 2016 5y median 47.9% FY 2025
Net Margin 41.9%
FY 2016: 44.6%FY 2017: 24.2%FY 2018: 36.2%FY 2019: -7.2%FY 2020: 34.7%FY 2021: 28.2%FY 2022: 37.6%FY 2023: 42.3%FY 2024: 41.5%FY 2025: 41.9%
FY 2016 5y median 41.5% FY 2025
ROE 18.8%
FY 2016: 38.3%FY 2017: 19.9%FY 2018: 21.1%FY 2019: -3.8%FY 2020: 15.2%FY 2021: 12.0%FY 2022: 15.2%FY 2023: 16.5%FY 2024: 18.5%FY 2025: 18.8%
FY 2016 5y median 16.5% FY 2025
ROIC 16.1%
FY 2016: 35.9%FY 2017: 18.2%FY 2018: 20.0%FY 2019: -3.2%FY 2020: 11.1%FY 2021: 9.2%FY 2022: 13.1%FY 2023: 13.5%FY 2024: 15.4%FY 2025: 16.1%
FY 2016 5y median 13.5% FY 2025
ROA 16.9%
FY 2016: 30.7%FY 2017: 14.5%FY 2018: 17.3%FY 2019: -2.7%FY 2020: 11.2%FY 2021: 9.2%FY 2022: 12.0%FY 2023: 13.7%FY 2024: 16.2%FY 2025: 16.9%
FY 2016 5y median 13.7% FY 2025

Growth (YoY)

Revenue 10.6%
FY 2016: 9.1%FY 2017: 7.9%FY 2018: -5.7%FY 2019: -11.0%FY 2020: 2.4%FY 2021: 13.6%FY 2022: 14.9%FY 2023: 20.2%FY 2024: 23.6%FY 2025: 10.6%
FY 2016 FY 2025
Operating Income 10.2%
FY 2016: 51.9%FY 2017: -23.2%FY 2018: -1.2%FY 2019: -123.3%FY 2020: 416.4%FY 2021: -6.4%FY 2022: 76.2%FY 2023: 20.9%FY 2024: 16.2%FY 2025: 10.2%
FY 2016 FY 2025
EPS (diluted) 13.1%
FY 2016: 19.9%FY 2017: -39.0%FY 2018: 43.8%FY 2019: -117.8%FY 2020: 582.8%FY 2021: -12.8%FY 2022: 49.1%FY 2023: 32.1%FY 2024: 24.4%FY 2025: 13.1%
FY 2016 FY 2025
Free Cash Flow -3.7%
FY 2016: 80.3%FY 2017: -35.4%FY 2018: 53.1%FY 2019: -148.9%FY 2020: 339.9%FY 2021: -31.4%FY 2022: 39.0%FY 2023: 12.6%FY 2024: 44.5%FY 2025: -3.7%
FY 2016 FY 2025

Financial Health

Current Ratio 6.6×
FY 2016: 4.3×FY 2017: 3.3×FY 2018: 6.4×FY 2019: 4.0×FY 2020: 6.7×FY 2021: 7.6×FY 2022: 9.8×FY 2023: 4.4×FY 2024: 5.2×FY 2025: 6.6×
FY 2016 5y median 6.6× FY 2025
Quick Ratio 6.3×
FY 2016: 4.0×FY 2017: 3.0×FY 2018: 6.0×FY 2019: 3.8×FY 2020: 6.4×FY 2021: 7.3×FY 2022: 9.6×FY 2023: 4.3×FY 2024: 5.0×FY 2025: 6.3×
FY 2016 5y median 6.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.3×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.8×
FY 2016: -0.9×FY 2017: -0.4×FY 2018: -0.5×FY 2019: -1.5×FY 2020: 0.1×FY 2021: -0.1×FY 2022: -0.2×FY 2023: -0.4×FY 2024: -0.8×FY 2025: -0.8×
FY 2016 5y median -0.4× FY 2025
Interest Coverage 77.8×
FY 2016: 272×FY 2017: 90.5×FY 2018: 57.9×FY 2019: -4.2×FY 2020: 25.3×FY 2021: 29.9×FY 2022: 30.2×FY 2023: 20.0×FY 2024: 32.1×FY 2025: 77.8×
FY 2016 5y median 30.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31